The association between MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4) and Glioma Susceptibility 1 is reported, with clinical genetic testing available.
Sources1
Clinical variants0
Symptoms9
Compounds0
Trials0
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.